Sodiumhexametaphosphate as Pulp Capping Material for Primary Teeth

Not Applicable

Not yet recruiting

• Conditions: Pulp Disease, Dental
• Interventions: Other: Pulp therapy; Drug: Sodiumhexametaphosphate; Other: MTA

• Registration Number: NCT06170775
• Lead Sponsor: Minia University

Brief Summary

Sodiumhexametaphosphate will be tested as pulp capping material in comparison to MTA for primary teeth pulp therapy

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-12
• Study First Submitted: 2023-12-06
• Study First Submitted QC: 2023-12-13
• Last Update Submitted: 2023-12-13
• Study First Posted: 2023-12-14
• Last Update Posted: 2023-12-14
• Study Start: 2023-12-20
• Primary Completion: 2024-12-20
• Study Completion: 2025-01-20

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• physical healthy children
• cooperative children
• primary molar with deep carious lesion
• absence of pain or transient momentary pain

Exclusion Criteria

• Uncooperative children
• children with systemic disorders
• periapical lesions
• sever pain

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Sodiumhexametaphosphate	Pulp therapy	-
Sodiumhexametaphosphate	Sodiumhexametaphosphate	-
MTA	Pulp therapy	-
MTA	MTA	-

Primary Outcome Measures

Name	Time	Method
Clinical success	One year	Absence of pain, swelling and sinus tract
Radiographic success	One year	Absence of periapical lesions, internal or external root resorption